Company Filing History:
Years Active: 2011
Title: Innovations in Ocular Health: The Contributions of Lourdes Ponce
Introduction
Lourdes Ponce is an accomplished inventor based in Germantown, MD (US). She has made significant contributions to the field of ocular health through her innovative research and patent. Her work focuses on addressing the challenges posed by unregulated angiogenesis, which is linked to various serious ocular diseases.
Latest Patents
Lourdes Ponce holds a patent for the therapeutic administration of the scrambled anti-angiogenic peptide C16Y. This invention is crucial in the fight against ocular neovascularization and tumor growth. The peptide sequence C16Y inhibits the development of new blood vessels, which is essential in treating conditions such as age-related macular degeneration and diabetic retinopathy. The invention outlines methods for treating these conditions using both full-length and truncated versions of the C16Y peptide.
Career Highlights
Lourdes Ponce is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to explore groundbreaking research in the field of ocular health. She has successfully translated her research into practical applications that can benefit patients suffering from serious eye diseases.
Collaborations
Lourdes has collaborated with notable colleagues, including Karl G Csaky and Hynda K Kleinman. These collaborations have further enriched her research and contributed to the advancement of knowledge in the field of angiogenesis and ocular health.
Conclusion
Lourdes Ponce's innovative work in developing the C16Y peptide represents a significant advancement in the treatment of ocular diseases. Her contributions to the field highlight the importance of research and innovation in improving patient outcomes.